DK2870246T3 - Oligonukleotid til behandlingen af patienter med muskeldystrofi - Google Patents

Oligonukleotid til behandlingen af patienter med muskeldystrofi Download PDF

Info

Publication number
DK2870246T3
DK2870246T3 DK13739847T DK13739847T DK2870246T3 DK 2870246 T3 DK2870246 T3 DK 2870246T3 DK 13739847 T DK13739847 T DK 13739847T DK 13739847 T DK13739847 T DK 13739847T DK 2870246 T3 DK2870246 T3 DK 2870246T3
Authority
DK
Denmark
Prior art keywords
oligonucleotide
treatment
muscular dystrophy
dystrophy patients
patients
Prior art date
Application number
DK13739847T
Other languages
English (en)
Inventor
Deutekom Judith Christina Theodora Van
Original Assignee
Biomarin Tech Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomarin Tech Bv filed Critical Biomarin Tech Bv
Priority claimed from PCT/NL2013/050487 external-priority patent/WO2014007620A2/en
Application granted granted Critical
Publication of DK2870246T3 publication Critical patent/DK2870246T3/da

Links

DK13739847T 2012-07-03 2013-07-03 Oligonukleotid til behandlingen af patienter med muskeldystrofi DK2870246T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261667517P 2012-07-03 2012-07-03
EP12174781 2012-07-03
PCT/NL2013/050487 WO2014007620A2 (en) 2012-07-03 2013-07-03 Oligonucleotide for the treatment of muscular dystrophy patients

Publications (1)

Publication Number Publication Date
DK2870246T3 true DK2870246T3 (da) 2019-11-25

Family

ID=65522559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13739847T DK2870246T3 (da) 2012-07-03 2013-07-03 Oligonukleotid til behandlingen af patienter med muskeldystrofi

Country Status (4)

Country Link
JP (2) JP6870891B2 (da)
DK (1) DK2870246T3 (da)
ES (1) ES2758982T3 (da)
HR (1) HRP20192007T1 (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078911B2 (en) * 2011-02-08 2015-07-14 The Charlotte-Mecklenburg Hospital Authority Antisense oligonucleotides

Also Published As

Publication number Publication date
ES2758982T3 (es) 2020-05-07
JP2019030330A (ja) 2019-02-28
JP2021105049A (ja) 2021-07-26
JP6870891B2 (ja) 2021-05-12
HRP20192007T1 (hr) 2020-02-07

Similar Documents

Publication Publication Date Title
HK1209456A1 (en) Oligonucleotide for the treatment of muscular dystrophy patients
HK1211589A1 (en) Compounds for the treatment of paramoxyvirus viral infections
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
EP3760257C0 (en) MEDICAL DEVICES FOR PREVENTING BLOOD REFLUX
DK2895156T3 (da) Fremgangsmåde til fremstilling af terapeutiske nanopartikler
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK2844279T3 (da) Doseringsprogrammer til behandling af pompes sygdom
EP2832384A4 (en) BLOOD PURIFICATION DEVICE
DK2869836T3 (da) Dna-vaccine til anvendelse hos patienter med pankreascancer
DK2872497T4 (da) Chromanyl-derivater til behandling af mitokondriel sygdom
DK2838907T3 (da) Aminosteroider til behandlingen af en ptp1b-associeret sygdom
DK2914310T3 (da) Medicinske indretninger med coatings til forbedret ekkogenicitet
DK2900259T3 (da) Glycosidase-regime til behandling af infektionssygdomme
DK2802351T3 (da) Midler til behandling af triple-negativ brystkræft
EP2712649A4 (en) MEDICAL TREATMENT INSTRUMENT
DK2938350T3 (da) Medicinsk formulering til behandling af hypercholesterolæmi
EP2572685A4 (en) TREATMENT INSTRUMENT OF LUMBAGO
PT2846774T (pt) Composição farmacêutica para o tratamento da distrofia muscular de duchenne
DK2694056T3 (da) Terapeutisk behandling
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
EP2869796A4 (en) PATIENT TREATMENT SYSTEM
DK2656075T3 (da) Fremgangsmåde til optimering af behandlingen af patienter med biologiske lægemidler
DK2872145T3 (da) Kondenserede benzazepiner til behandling af tourettes syndrom
DK2870246T3 (da) Oligonukleotid til behandlingen af patienter med muskeldystrofi
PL395785A1 (pl) Zastosowanie medyczne N-etylo-3-amino-4-fenylo-5-okso-2,5-dihydro-1H-pirazolo-1-karbotioamidu